Evidence map›Paper›PMID 35663505›Full record

ArticleChemical engineering journal (Lausanne, Switzerland : 1996)2022

COVID-19-inspired "artificial virus" to combat drug-resistant bacteria by membrane-intercalation- photothermal-photodynamic multistage effects.

Yongsheng Ni, Jingyao Wang, Mengyi Wang, Lizhi Liu, Hongqing Nie, Qiaoling Wang, Jing Sun, Tianli Yue, Ming-Qiang Zhu, Jianlong Wang

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemical engineering journal (Lausanne, Switzerland : 1996), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Yongsheng NiCollege of Food Science and Engineering, Northwest A&F University, Yangling 712100, Shaanxi, China.
Jingyao WangCollege of Food Science and Engineering, Northwest A&F University, Yangling 712100, Shaanxi, China.
Mengyi WangCollege of Food Science and Engineering, Northwest A&F University, Yangling 712100, Shaanxi, China.
Lizhi LiuDepartment of Applied Physics, University of Eastern Finland, 70210 Kuopio, Finland.
Hongqing NieCollege of Food Science and Engineering, Northwest A&F University, Yangling 712100, Shaanxi, China.
Qiaoling WangCollege of Food Science and Engineering, Northwest A&F University, Yangling 712100, Shaanxi, China.
Jing SunQinghai Provincial Key Laboratory of Qinghai-Tibet Plateau Biological Resources, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Qinghai 810008, China.
Tianli YueCollege of Food Science and Engineering, Northwest A&F University, Yangling 712100, Shaanxi, China.
Ming-Qiang ZhuCollege of Mechanical and Electronic Engineering, Northwest A&F University, Yangling 712100, China.
Jianlong WangCollege of Food Science and Engineering, Northwest A&F University, Yangling 712100, Shaanxi, China.
Northwest A&F University · CNUniversity of Eastern Finland · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 threatens human life because of the super destructiveness produced from its coronal morphology and strong transmembrane infection based on spike glycoprotein. Inspired by the coronal morphology of COVID-19 and its means of infecting, we designed an "artificial virus" with coronal morphology based on the concept of "defeating superbacteria with superviruses" by self-assembling a transacting activator of transduction peptide with triple-shell porous graphitic carbon nitride (g-C

Indexed as

Bio-inspiredCOVID-19Drug-resistant bacteria

Identifiers

PMID35663505
PMCPMC9153178
OpenAlexW4281646905

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.